![Keith Murphy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Keith Murphy
Directeur Général chez
VIVOSIM LABS, INC.
Fortune : 12 938 $ au 30/06/2026
Profil
Keith Murphy was the founder of VivoSim Labs, Inc., founded in 2007, where the title held was Chairman in 2017.
Mr. Murphy was the founder of Organovo, Inc., founded in 2012, where the title held was Chairman, President & Chief Executive Officer in 2017.
Mr. Murphy is the founder of Viscient Biosciences LLC, founded in 2017, holding the titles of Chairman & Chief Executive Officer since 2017.
Current jobs included Executive Chairman, CEO & Secretary at VivoSim Labs, Inc. since 2020; Co-Chairman at No Patient Left Behind; Director at California Biomedical Innovation Alliance since 2016; Director at California Life Sciences Association; Independent Director at Matinas BioPharma Holdings, Inc. starting 2025; and Executive Advisor at Methuselah Capital Management LLC.
Former jobs include Vice Chairman at Alliance for Regenerative Medicine; Director-Process Development at Amgen, Inc. from 1997 to 2007; Independent Director at Kintara Therapeutics, Inc. from 2020 to 2022; Director at Adgero Biopharmaceuticals Holdings, Inc.; and Head-Development at Alkermes Plc from 1993 to 1997.
Education includes an undergraduate degree from Massachusetts Institute of Technology conferred in 2004 and a graduate degree from UCLA Anderson School of Management conferred in 1993.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VIVOSIM LABS INC 0,47 % | 15/06/2026 | 12 092 ( 0,47 % ) | 12 938 $ | 30/06/2026 |
Postes actifs de Keith Murphy
| Sociétés | Poste | Début |
|---|---|---|
| VIVOSIM LABS, INC. | Directeur Général | 15/09/2020 |
| MATINAS BIOPHARMA HOLDINGS, INC. | Directeur/Membre du Conseil | 11/03/2025 |
California Biomedical Innovation Alliance
 California Biomedical Innovation Alliance BiotechnologyHealth Technology Provides biomedical advocacy and community services | Directeur/Membre du Conseil | 24/05/2016 |
Viscient Biosciences LLC
 Viscient Biosciences LLC BiotechnologyHealth Technology Develops drugs across a range of therapeutic areas | Directeur Général | 01/01/2017 |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Directeur/Membre du Conseil | - |
Methuselah Capital Management LLC
 Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management invests in companies located in the United States. The firm target companies operating across a broad range of sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
No Patient Left Behind
 No Patient Left Behind No Patient Left Behind is a non-profit company dedicated to ensuring that all patients have access to necessary medications and healthcare services. The company is based in Washington, DC. It focuses on advocating for policy changes and providing resources to help patients navigate the healthcare system. Through its initiatives, No Patient Left Behind aims to eliminate barriers to healthcare and promote equitable treatment for all individuals. The company was founded by Peter Kolchinsky. | Président | - |
Anciens postes connus de Keith Murphy
| Sociétés | Poste | Fin |
|---|---|---|
| KINTARA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 04/02/2022 |
| VIVOSIM LABS, INC. | Directeur Général | 21/04/2017 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Keith Murphy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
VivoSim Labs, Inc.
 VivoSim Labs, Inc. BiotechnologyHealth Technology Engages in developing and commercializing functional human tissues | Health Technology |
Kintara Therapeutics, Inc.
 Kintara Therapeutics, Inc. BiotechnologyHealth Technology Develops novel cancer therapies | Health Technology |
Organovo, Inc.
 Organovo, Inc. Medical/Nursing ServicesHealth Services Operates as an early-stage medical laboratory and research company focused on human tissue development | Health Services |
Matinas BioPharma Holdings, Inc.
 Matinas BioPharma Holdings, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Alkermes Plc
 Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Biomedical Innovation Alliance
California Biomedical Innovation Alliance BiotechnologyHealth Technology Provides biomedical advocacy and community services | Health Technology |
Adgero Biopharmaceuticals Holdings, Inc.
 Adgero Biopharmaceuticals Holdings, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company focused on building a robust pipeline for oncology indications | Health Technology |
Methuselah Capital Management LLC
Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management invests in companies located in the United States. The firm target companies operating across a broad range of sectors. It provides financing for early stage capital requirements. | Finance |
Viscient Biosciences LLC
Viscient Biosciences LLC BiotechnologyHealth Technology Develops drugs across a range of therapeutic areas | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
No Patient Left Behind
No Patient Left Behind No Patient Left Behind is a non-profit company dedicated to ensuring that all patients have access to necessary medications and healthcare services. The company is based in Washington, DC. It focuses on advocating for policy changes and providing resources to help patients navigate the healthcare system. Through its initiatives, No Patient Left Behind aims to eliminate barriers to healthcare and promote equitable treatment for all individuals. The company was founded by Peter Kolchinsky. |
